Impact of hepatitis C virus co-infection on HIV patients before and after highly active antiretroviral therapy: an immunological and clinical chemistry observation, Addis Ababa, Ethiopia.

BMC immunology

Volumn 14, Issue , 2013, Pages

  Taye, Solomon ^a   Lakew, Mekuria ^b  

^a MADDA WALABU UNIVERSITY   (Ethiopia)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CD4 LYMPHOCYTE COUNT; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CLINICAL CHEMISTRY; ENZYMOLOGY; ETHIOPIA; FEMALE; GENERAL HOSPITAL; HEPATITIS C; HEPATITIS C VIRUS; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOLOGY; LIVER; MALE; MIXED INFECTION; PATHOLOGY; PHYSIOLOGY; PREVALENCE; PROPORTIONAL HAZARDS MODEL; STATISTICS; SURVIVAL; VIROLOGY;

ADULT; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; CD4 LYMPHOCYTE COUNT; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CHEMISTRY, CLINICAL; COINFECTION; ETHIOPIA; FEMALE; HEPACIVIRUS; HEPATITIS C; HIV INFECTIONS; HOSPITALS, GENERAL; HUMANS; LIVER; MALE; PREVALENCE; PROPORTIONAL HAZARDS MODELS; SURVIVAL ANALYSIS;

MLCS; MLOWN;

EID: 84877804871     PISSN: None     EISSN: 14712172     Source Type: None    
DOI: 10.1186/1471-2172-14-23     Document Type: Article

References (0)